Wilhelm, R.; Eckes, T.; Imre, G.; Kippenberger, S.; Meissner, M.; Thomas, D.; Trautmann, S.; Merlio, J.-P.; Chevret, E.; Kaufmann, R.;
et al. C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers 2021, 13, 270.
https://doi.org/10.3390/cancers13020270
AMA Style
Wilhelm R, Eckes T, Imre G, Kippenberger S, Meissner M, Thomas D, Trautmann S, Merlio J-P, Chevret E, Kaufmann R,
et al. C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers. 2021; 13(2):270.
https://doi.org/10.3390/cancers13020270
Chicago/Turabian Style
Wilhelm, Raphael, Timon Eckes, Gergely Imre, Stefan Kippenberger, Markus Meissner, Dominique Thomas, Sandra Trautmann, Jean-Philippe Merlio, Edith Chevret, Roland Kaufmann,
and et al. 2021. "C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma" Cancers 13, no. 2: 270.
https://doi.org/10.3390/cancers13020270
APA Style
Wilhelm, R., Eckes, T., Imre, G., Kippenberger, S., Meissner, M., Thomas, D., Trautmann, S., Merlio, J.-P., Chevret, E., Kaufmann, R., Pfeilschifter, J., Koch, A., & Jäger, M.
(2021). C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers, 13(2), 270.
https://doi.org/10.3390/cancers13020270